Aceclofenac (Vitafen®)
Aceclofenac (Vitafen®) is indicated for the relief of pain and inflammation in osteoarthritis, rheumatoid arthritis and ankylosing spondylitis.
Rapid Review
| Commenced | Completed | Outcome |
| 22/07/2016
|
24/08/2016
|
Reimbursement not recommended
|
| 21/12/2016 | 24/01/2017 | Following a resubmission of the rapid review a full pharmacoeconomic evaluation is recommended at the submitted price. |
The HSE has approved reimbursement following confidential price negotiations Nov 2017.